Quarterly report pursuant to Section 13 or 15(d)

Interim Consolidated Statements of Cash Flow

v3.23.1
Interim Consolidated Statements of Cash Flow - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Cash provided by (used for): Operating activities    
Net loss for the period $ (713) $ (6,928)
Items not affecting cash:    
Stock based compensation 253 261
Net realizable value adjustments 2,875 1,722
Amortization of mineral properties 313 312
Depreciation of capital assets 473 456
Accretion expense 122 112
Amortization of deferred loan costs 11 11
Mark to market loss (gain) (1,867) 2,973
Unrealized foreign exchange loss (gain) (336) 11
Accounts receivable (2) (2)
Inventory 753 (1,722)
Prepaid expenses (168) (158)
Accounts payable and accrued liabilities 613 730
Net cash provided by used in operating activities 2,327 (2,222)
Investing activities    
Purchase of capital assets (665) (60)
Net Cash Provided By Used In Investing Activities (665) (60)
Financing activities    
Issuance of common shares and warrants for cash 46,637 2,128
Share issue costs (2,914) (53)
Proceeds from exercise of warrants and stock options 298 365
Repayment of debt (1,324) 0
Net Cash Provided By Used In Financing Activities 42,697 2,440
Effects of foreign exchange rate changes on cash 0 22
Increase in cash, cash equivalents, and restricted cash 44,359 180
Beginning cash, cash equivalents, and restricted cash 41,140 54,155
Ending cash, cash equivalents, and restricted cash $ 85,499 $ 54,335